CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
Doxycycline 100mg +1 moredrug
Likely dose
Doxycycline 100mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01885910
NCT01885910Phase 4Completed

Use of Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel Treatment

Derm Research, PLLC·interventional·Posted Jun 25, 2013·Updated Feb 27, 2015

In Brief

A Phase 4 clinical trial evaluating Doxycycline 100mg and Aczone 5% gel for Acne Vulgaris. Completed, enrolled 32 participants across 1 site.

Detailed Summary

This pilot study will explore if continuation of treatment of treatment with Aczone 5% gel following combination treatment with with doxycycline and Aczone 5% gel can maintain therapeutic response.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
CollaboratorsWFH MEDICAL, LLC

Timeline

Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 25, 2013
Enrollment StartJul 1, 2013
Primary CompletionJul 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.0 years ago

Interventions

Doxycycline 100mgdrug

Doxycycline 100mg by mouth once daily

Aczone 5% geldrug

Aczone 5% gel twice daily